Go to:
Logótipo
Você está em: Start » Publications » View » Role of cAMP-PKA-PLC signaling cascade on dopamine-induced PKC-mediated inhibition of renal Na+-K+-ATPase activity
Publication

Role of cAMP-PKA-PLC signaling cascade on dopamine-induced PKC-mediated inhibition of renal Na+-K+-ATPase activity

Title
Role of cAMP-PKA-PLC signaling cascade on dopamine-induced PKC-mediated inhibition of renal Na+-K+-ATPase activity
Type
Article in International Scientific Journal
Year
2002
Authors
Pedro Gomes
(Author)
Other
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
soares-da-silva, p
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Journal
Other information
Authenticus ID: P-000-P2Q
Abstract (EN): We studied the molecular events set into motion by stimulation of D-1-like receptors downstream of Na+-K+-ATPase, while measuring apical-to-basal ouabain-sensitive, amphotericin B-induced increases in short-circuit current in opossum kidney (OK) cells. The D-1-like receptor agonist SKF-38393 decreased Na+-K+-ATPase activity (IC50, 130 nM). This effect was prevented by the D-1-like receptor antagonist SKF-83566, overnight cholera toxin treatment, the protein kinase A (PKA) antagonist H-89, or the PKC antagonist chelerythrine, but not the mitogen-activated PK inhibitor PD-098059 or phosphatidylinositol 3-kinase inhibitors wortmannin and LY-294002. Dibutyryl cAMP (DBcAMP) and phorbol 12,13-dibutyrate (PDBu) both effectively reduced Na+-K+-ATPase activity. PKA downregulation abolished the inhibitory effects of SKF-38393 and DBcAMP but not those of PDBu. PKC downregulation abolished inhibition by PDBu, SKF-38393, and DBcAMP. The phospholipase C (PLC) inhibitor U-73122 prevented inhibition by SKF-38393 and DBcAMP. However, DBcAMP increased PLC activity. Although OK cells express both G(s)alpha and G(q/11)alpha proteins, D-1-like receptors are coupled to G(s)alpha proteins only, as evidenced by studies in cells treated overnight with specific antibodies raised against G(s)alpha and G(q/11)alpha proteins. We conclude that PLC and Na+-K+-ATPase are effector proteins for PKA and PKC, respectively, after stimulation of D-1-like receptors coupled to G(s)alpha proteins, in a sequence of events that begins with adenylyl cyclase-PKA system activation followed by PLC-PKC system activation.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 13
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

α2C-Adrenoceptors modulate L-DOPA uptake in opossum kidney cells and in the mouse kidney (2012)
Article in International Scientific Journal
Maria Augusta Coelho
Renalase regulates renal dopamine and phosphate metabolism (2013)
Article in International Scientific Journal
Sizova D; Velazquez H; Benedita Sampaio-Maia; Quelhas Santos, J; Pestana M, Desir GV.
Renalase regulates peripheral and central dopaminergic activities (2015)
Article in International Scientific Journal
Quelhas Santos, J; Serrao, MP; Soares Silva, I; Fernandes Cerqueira, C; Simoes Silva, L; Pinho, MJ; Remiao, F; Sampaio Maia, B; Desir, GV; Pestana, M
Inhibition of cholinergic neurotransmission by beta(3)-adrenoceptors depends on adenosine release and A(1)-receptor activation in human and rat urinary (2017)
Article in International Scientific Journal
Silva, I; Costa, AF; Moreira, S; Ferreirinha, F; Magalhaes Cardoso, MT; Calejo, I; Silva Ramos, M; Paulo Correia de Sá
High-salt intake and the renal expression of amino acid transporters in spontaneously hypertensive rats (2007)
Article in International Scientific Journal
Maria João Pinho; Maria Paula Serrão; Patrício Soares da Silva

See all (11)

Recommend this page Top
Copyright 1996-2024 © Faculdade de Medicina da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z  I Guest Book
Page created on: 2024-11-07 at 09:46:10
Acceptable Use Policy | Data Protection Policy | Complaint Portal | Política de Captação e Difusão da Imagem Pessoal em Suporte Digital